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Materials and Methods 
 
Unless otherwise stated, reactions were performed in flame-dried glassware under an 
argon or nitrogen atmosphere using dry, deoxygenated solvents. Solvents were dried by 
passage through an activated alumina column under argon. Commercially obtained 
reagents were used as received. Chemicals were purchased from Sigma 
Aldrich/Strem/Alfa Aesar/Oakwood Chemicals and used as received.  Reaction 
temperatures were controlled by an IKAmag temperature modulator. Glove box 
manipulations were performed under a nitrogen atmosphere. Thin-layer chromatography 
(TLC) and preparatory TLC was performed using E. Merck silica gel 60 F254 precoated 
plates (0.25 mm) and visualized by UV fluorescence quenching, KMnO4 or p-
anisaldehyde staining. SiliaFlash P60 Academic Silica gel (particle size 0.040–0.063 
mm) was used for flash chromatography. Analytical chiral HPLC was performed with an 
Agilent 1100 Series HPLC utilizing a Chiralpak IC column (4.6 mm x 25 cm) or a 
Chiralpak AD column (4.6 mm x 25 cm), both obtained from Daicel Chemical Industries, 
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Ltd. with visualization at 210 nm. Analytical SFC was performed with a Mettler SFC 
supercritical CO2 analytical chromatography system utilizing a Chiralpak IC-3 column 
(4.6 mm x 25 cm) obtained from Daicel Chemical Industries, Ltd. with visualization at 
210 nm. 1H NMR spectra were recorded on a Bruker Avance HD 400 MHz spectrometer 
and are reported relative to residual CHCl3  (δ 7.26 ppm). 13C NMR spectra were 
recorded on a Bruker Avance HD 400 MHz spectrometer and are reported relative to 
residual CDCl3  (δ 77.16 ppm). Data for 1H NMR are reported as follows: s = singlet, d = 
doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, br s = broad 
singlet. Data for 13C NMR are reported in terms of chemical shifts (δ ppm). Some 
reported spectra include minor solvent impurities of benzene (δ 7.36 ppm), water (δ 1.56 
ppm), ethyl acetate (δ 4.12, 2.05, 1.26 ppm), methylene chloride (δ 5.30 ppm), grease (δ 
1.26, 0.86 ppm), and/or silicon grease (δ 0.07 ppm), which do not impact product 
assignments. IR spectra were obtained using a Perkin Elmer Paragon 1000 spectrometer 
using thin films deposited on NaCl plates and reported in frequency of absorption (cm-1). 
High resolution mass spectra (HRMS) were obtained from the Caltech Mass Spectral 
Facility using a JEOL JMS-600H High Resolution Mass Spectrometer in fast atom 
bombardment (FAB+) or electron ionization (EI+) mode, or an Agilent 6200 Series TOF 
with an Agilent G1978A Multimode source in electrospray ionization (ESI+), 
atmospheric pressure chemical ionization (APCI+), or mixed ionization mode (MM: ESI-
APCI+). Optical rotations were measured with a Jasco P-2000 polarimeter operating on 
the sodium D-line (589 nm), using a 100 mm pathlength cell and are reported as: [α]DT 
(concentration in g/100 mL, solvent).  
 
List of Abbreviations: ee – enantiomeric excess, HPLC – high-performance liquid 
chromatography, SFC – supercritical fluid chromatography, TLC – thin-layer 
chromatography, EtOAc – ethyl acetate, THF – tetrahydrofuran, MeOH – methanol,  
Et2O – diethyl ether, TBD – 1,5,7-triazabicyclo[4.4.0]dec-5-ene, cod – cis,cis-1,5-
cyclooctadiene, DIBAL – diisobutylaluminium hydride, MAC – masked acyl cyanide 
 
Preparation of Known Compounds: Previously reported methods were used to prepare 









(E)-3-(3-Chlorophenyl)allyl methyl carbonate (5e). To a solution of methyl (E)-3-(3-
chlorophenl)prop-2-enoate8 (1.4 g, 7.0 mmol, 1 equiv) in Et2O (28 mL) at –78 °C was 
added DIBAL (3.0 g, 21 mmol, 3 equiv) dropwise. The resulting reaction mixture was 
stirred at –78 °C for 2.5 h, whereupon the reaction was quenched with a saturated 
aqueous Rochelle’s salt solution (10 mL). The cooling bath was then removed and the 
reaction was stirred for 18 h at ambient temperature. The aqueous layer was extracted 
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with CH2Cl2 (3 x 50 mL) and the combined organic layers were washed with brine (50 
mL), dried over Na2SO4, and concentrated under reduced pressure.   
 
The crude material was then dissolved in CH2Cl2 (10 mL) and cooled to 0 °C. Pyridine 
(1.7 mL, 21 mmol, 3 equiv) was added followed by methyl chloroformate (0.81 mL, 11 
mmol, 1.5 equiv) dropwise. The resulting solution was allowed to warm to ambient 
temperature and stirred for 18 h. The reaction was quenched with the addition of 1 M 
HCl (10 mL) and the aqueous layer was extracted with CH2Cl2 (3 x 50 mL). The 
combined organic layers were washed with brine (50 mL), dried over Na2SO4, and 
concentrated under reduced pressure. The crude product was purified by silica gel flash 
column chromatography (5% EtOAc/hexanes) to give carbonate 5e as a colorless oil (1.0 
g, 63% yield): 1H NMR (400 MHz, CDCl3) δ 7.43 – 7.37 (m, 1H), 7.30 – 7.23 (m, 3H), 
6.69 – 6.60 (m, 1H), 6.32 (dt, J = 15.9, 6.3 Hz, 1H), 4.81 (dd, J = 6.3, 1.4 Hz, 2H), 3.84 
(s, 3H); 13C NMR (101 MHz, CDCl3) δ 155.7, 138.0, 134.7, 133.2, 130.0, 128.3, 126.7, 
125.0, 124.2, 68.1, 55.1; IR (Neat Film, NaCl) 3010, 2956, 2856, 1748, 1594, 1567, 
1442, 1377, 1261, 1091, 1078, 962, 791, 777, 682 cm-1; HRMS (MM: FAB+) m/z calc’d 
for C11H11ClO3 [M]+: 226.0397, found 226.0398. 
 
 






(E)-3-(Benzo[d][1,3]dioxol-5-yl)allyl methyl carbonate (5f). Carbonate 5f was prepared 
from methyl (2E)-3-(1,3-benzodioxol-5-yl)acrylate9 according to the general procedure 
and isolated by silica gel flash column chromatography (5% EtOAc/hexanes) as a 
colorless solid (0.79 g, 48% yield): 1H NMR (400 MHz, CDCl3) δ 6.93 (d, J = 1.6 Hz, 
1H), 6.83 (ddd, J = 7.9, 1.6, 0.5 Hz, 1H), 6.79 – 6.73 (m, 1H), 6.60 (dt, J = 15.7, 1.3 Hz, 
1H), 6.12 (dt, J = 15.7, 6.6 Hz, 1H), 5.96 (s, 2H), 4.76 (dd, J = 6.6, 1.3 Hz, 2H), 3.80 (s, 
3H); 13C NMR (101 MHz, CDCl3) δ 155.8, 148.2, 147.9, 134.9, 130.6, 121.8, 120.7, 
108.4, 106.0, 101.3, 68.7, 55.0; IR (Neat Film, NaCl) 3003, 2956, 2895, 2781, 1747, 
1504, 1491, 1446, 1384, 1355, 1252, 1194, 1126, 1103, 1039, 933, 863, 791 cm-1; HRMS 









(E)-Methyl (3-(3,4,5-trimethoxyphenyl)allyl) carbonate (5g). Carbonate 5g was 
prepared from methyl 3,4,5-trimethoxycinnamate10 according to the general procedure 
and isolated by silica gel flash column chromatography (5% EtOAc/hexanes) as a 
colorless oil (1.2 g, 65% yield): 1H NMR (400 MHz, CDCl3) δ 6.65 – 6.56 (m, 3H), 6.21 
(dt, J = 15.8, 6.5 Hz, 1H), 4.78 (dd, J = 6.5, 1.3 Hz, 2H), 3.87 (s, 6H), 3.84 (s, 3H), 3.81 
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(s, 3H); 13C NMR (101 MHz, CDCl3) δ 155.8, 153.4, 138.4, 135.0, 131.8, 122.0, 103.9, 
68.5, 61.1, 56.2, 55.0; IR (Neat Film, NaCl) 2999, 2956, 2840, 1748, 1583, 1508, 1452, 
1420, 1339, 1265, 1128, 1010, 941, 850, 792 cm-1; HRMS (FAB+) m/z calc’d for 
C14H18O6 [M]+: 282.1103, found 282.1114. 
 
 
General Procedure for Optimization Reactions (Table 1) 
 
In a nitrogen-filled glove box, to a 1 dram vial (vial A) equipped with a stir bar was 
added [Ir(cod)Cl]2 (1.3 mg, 0.0020 mmol, 2 mol %), ligand 3 (1.8 mg, 0.0040 mmol, 4 
mol %), TBD (1.4 mg, 0.010 mmol, 10 mol%), and THF (0.5 mL). Vial A was stirred at 
25 °C (ca. 10 min) while another 1 dram vial (vial B) was charged with LiBr (17 mg, 
0.20 mmol, 200 mol %), MAC nucleophile 1 (0.20 mmol), and THF (0.25 mL). The pre-
formed catalyst solution (vial A) was then transferred to vial B followed by 0.25 mL of a 
solution of cinnamyl carbonate 2 (0.4 M in THF). The vial was sealed and stirred at the 
specified temperature. After 18 or 48 h, the vial was removed from the glove box and 
filtered through a pad of silica, rinsing with EtOAc. The crude mixture was concentrated 
and 1,2,4,5-tetrachloro-3-nitrobenzene (0.10 mmol in 0.5 mL CDCl3) was added. The 
NMR yield (measured in reference to 1,2,4,5-tetrachloro-3-nitrobenzene δ 7.74 ppm (s, 
1H)) was determined by 1H NMR analysis of the crude mixture. The residue was purified 
by preparatory TLC (15% EtOAc/hexanes) to afford product 4, which was analyzed by 
chiral HPLC (1% IPA, 1.0 mL/min, Chiralpak IC column, λ = 210 nm). 
 
 
General Procedure for the Ir-Catalyzed Allylic Alkylation 
 
Please note that the absolute configuration of product 4c was assigned by conversion to 
(R)-2-phenylbutanoic acid.11 All other products (6a–l) were assigned by analogy. For 







(R)-2-(Methoxymethoxy)-2-(1-phenylallyl)malononitrile (4c). In a nitrogen-filled 
glove box, to a 1 dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (2.7 
mg, 0.0040 mmol, 2 mol %), ligand 3 (3.7 mg, 0.0080 mmol, 4 mol %), TBD (2.8 mg, 
0.020 mmol, 10 mol %), and THF (1 mL). Vial A was stirred at 25 °C (ca. 10 min) while 
another 1 dram vial (vial B) was charged with LiBr (35 mg, 0.40 mmol, 200 mol %), 
MAC nucleophile 1c (50 mg, 0.40 mmol, 200 mol %), and THF (0.5 mL). The pre-
formed catalyst solution (vial A) was then transferred to vial B followed by a solution of 
cinnamyl carbonate 2 (38 mg, 0.20 mmol, 100 mol %) in THF (0.5 mL). The vial was 
sealed and stirred at 60 °C. After 18 h, the vial was removed from the glove box and 
filtered through a pad of silica, rinsing with EtOAc. The crude mixture was concentrated 
and the resulting residue was purified by silica gel flash column chromatography (10% 
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EtOAc/hexanes) to give the product 4c as a colorless oil (41 mg, 85% yield): 95% ee; 
[α]D25 –41.3 (c 2.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.32 (m, 5H), 6.29 
(ddd, J = 16.9, 10.3, 8.6 Hz, 1H), 5.53 – 5.38 (m, 2H), 5.06 – 4.94 (m, 2H), 3.97 – 3.91 
(m, 1H), 3.44 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 134.4, 131.5, 129.6, 129.1, 128.9, 
122.7, 112.7, 112.7, 96.5, 69.9, 58.4, 57.4; IR (Neat Film, NaCl) 3065, 3033, 2961, 2904, 
2851, 2244, 1750, 1496, 1455, 1420, 1267, 1217, 1164, 1109, 1053, 1033, 967, 940, 791, 
732, 700 cm-1; HRMS (FAB+) m/z calc’d for C14H15N2O2 [M+H]+: 243.1131, found 
243.1134; HPLC conditions: 1% IPA, 1.0 mL/min, Chiralpak IC column, λ = 210 nm, tR 
(min): major = 12.831, minor = 17.466. 
 
 







(R)-2-(Methoxymethoxy)-2-(1-phenylallyl)malononitrile (4c). In a nitrogen-filled 
glove box, a solution of [Ir(cod)Cl]2 (106 mg, 0.16 mmol, 2 mol %), ligand 3 (145 mg, 
0.32 mmol, 4 mol %), TBD (110 mg, 0.79 mmol, 10 mol %) in THF (20 mL) was stirred 
at 25 °C. After 10 minutes, the catalyst mixture was added to a mixture of LiBr (0.69 g, 
7.9 mmol, 200 mol %), MAC nucleophile 1c (1 g, 7.9 mmol, 200 mol %), and THF (20 
mL) followed by cinnamyl carbonate 2 (0.76 g, 4.0 mmol, 100 mol %). The flask was 
removed from the glove box and stirred at 60 °C. After 18 h, the crude reaction mixture 
was concentrated and the resulting residue was purified by silica gel flash column 
chromatography (10% EtOAc/hexanes) to give the product 4c as a colorless oil (0.82 g, 
86% yield): 95% ee, spectroscopic data vide supra.  
 
 







(R)-2-(1-(4-Bromophenyl)allyl)-2-(methoxymethoxy)malononitrile (6a). Product 6a 
was prepared according to the general procedure and isolated by silica gel flash column 
chromatography (10% EtOAc/hexanes) to give a colorless oil (60 mg, 94% yield): 96% 
ee; [α]D25 –44.3 (c 3.2, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.56 – 7.50 (m, 2H), 7.32 
– 7.28 (m, 2H), 6.23 (ddd, J = 16.9, 10.3, 8.6 Hz, 1H), 5.55 – 5.38 (m, 2H), 5.05 – 4.96 
(m, 2H), 3.92 (d, J = 8.6 Hz, 1H), 3.44 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 133.4, 
132.1, 131.3, 130.9, 123.4, 123.2, 112.6, 112.5, 96.6, 69.5, 57.8, 57.5; IR (Neat Film, 
NaCl) 3013, 2934, 2242, 1488, 1404, 1274, 1216, 1163, 1108, 1034, 1010, 967, 939, 826, 
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762 cm-1; HRMS (FAB+) m/z calc’d for C14H13BrO2N2 [M]+: 320.0160, found 320.0155; 
HPLC conditions: 1% IPA, 1.0 mL/min, Chiralpak IC column, λ = 210 nm, tR (min): 









Product 6b was prepared according to the general procedure and isolated by preparatory 
TLC (5% EtOAc/hexanes, plate eluted three times) to give a pale yellow oil (36 mg, 58% 
yield): 96% ee; [α]D25 –25.2 (c 1.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 
8.6 Hz, 2H), 7.55 (d, J = 8.2 Hz, 2H), 6.27 (ddd, J = 16.9, 10.3, 8.7 Hz, 1H), 5.57 – 5.41 
(m, 2H), 5.09 – 4.96 (m, 2H), 4.02 (d, J = 8.7 Hz, 1H), 3.44 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δ 138.4, 131.5, 131.1, 130.6, 130.2, 125.9 (q, J = 3.9 Hz), 125.3, 123.6, 122.6, 
112.5, 112.4, 96.7, 69.4, 58.0, 57.6; IR (Neat Film, NaCl) 2962, 2906, 2835, 2245, 1751, 
1618, 1445, 1417, 1445, 1417, 1327, 1269, 1218, 1166, 1127, 1069, 943, 840, 792 cm-1; 
HRMS (MM: FAB+) m/z calc’d for C15H12F3N2O2 [(M+H)–H2]–: 309.0851, found 
309.0849; HPLC conditions: 1% IPA, 1.0 mL/min, Chiralpak IC column, λ = 210 nm, tR 








(R)-2-(1-(4-Fluorophenyl)allyl)-2-(methoxymethoxy)malononitrile (6c). Product 6c 
was prepared according to the general procedure and isolated by preparatory TLC (9% 
EtOAc/hexanes, plate eluted two times) to give a colorless oil (37 mg, 69% yield): 96% 
ee; [α]D25 –35.9 (c 1.9, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.32 (m, 2H), 7.15 
– 7.02 (m, 2H), 6.25 (ddd, J = 16.9, 10.3, 8.5 Hz, 1H), 5.57 – 5.35 (m, 2H), 5.11 – 4.94 
(m, 2H), 3.95 (d, J = 8.5 Hz, 1H), 3.44 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 164.3, 
161.9, 131.5, 131.4, 131.2, 130.2 (d, J = 3.5 Hz), 122.9, 116.1, 115.9, 112.7, 112.6, 96.6, 
69.8 (d, J = 1.6 Hz), 57.5 (d, J = 9.2 Hz); IR (Neat Film, NaCl) 3085, 2964, 2847, 2242, 
1606, 1511, 1415, 1281, 1230, 1164, 1108, 1053, 968, 940, 798, 766 cm-1; HRMS (ESI+) 
m/z calc’d for C14H14N2O2F [M+H]+: 261.1039, found 261.1033; HPLC conditions: 1% 












(R)-2-(Methoxymethoxy)-2-(1-(4-methoxyphenyl)allyl)malononitrile (6d). Product 6d 
was prepared according to the general procedure and isolated by silica gel flash column 
chromatography (5–10% EtOAc/hexanes) to give a colorless oil (52 mg, 95% yield): 
95% ee; [α]D25 –51.8 (c 2.7, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.41 – 7.31 (m, 2H), 
6.92 (d, J = 8.8 Hz, 2H), 6.26 (ddd, J = 16.9, 10.3, 8.5 Hz, 1H), 5.61 – 5.34 (m, 2H), 5.08 
– 4.94 (m, 2H), 3.91 (d, J = 8.5 Hz, 1H), 3.82 (s, 3H), 3.45 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δ 160.1, 131.7, 130.8, 126.3, 122.3, 114.3, 112.82, 112.78, 96.5, 70.1, 57.6, 57.4, 
55.4; IR (Neat Film, NaCl) 3005, 2962, 2939, 2905, 2838, 2244, 2052, 1890, 1610, 1584, 
15112, 1459, 1305, 1252, 1216, 1182, 1162, 1107, 1031, 937, 834, 783, 765, 625 cm-1; 
HRMS (FAB+) m/z calc’d for C15H17N2O3 [M+H]+: 273.1239, found 273.1227; SFC 
conditions: 3% IPA, 3.5 mL/min, Chiralpak IC-3 column, λ = 210 nm, tR (min): major = 








(R)-2-(1-(3-Chlorophenyl)allyl)-2-(methoxymethoxy)malononitrile (6e). Product 6e 
was prepared according to the general procedure and isolated by silica gel flash column 
chromatography (10% EtOAc/hexanes) to give a colorless oil (47 mg, 85% yield): 92% 
ee; [α]D25 –38.5 (c 2.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.28 (m, 4H), 6.23 
(ddd, J = 16.9, 10.3, 8.7 Hz, 1H), 5.57 – 5.40 (m, 2H), 5.08 – 4.97 (m, 2H), 3.92 (d, J = 
8.7 Hz, 1H), 3.45 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 136.4, 134.7, 130.8, 130.2, 
129.9, 129.3, 127.8, 123.3, 112.6, 112.4, 96.6, 69.5, 57.9, 57.5; IR (Neat Film, NaCl) 
3069, 2962, 2849, 2832, 2244, 1751, 1596, 1576, 1478, 1436, 1418, 1277, 1217, 1164, 
1109, 111055, 1032, 967, 940, 884, 797, 760, 730, 713, 690 cm-1; HRMS (ESI+) m/z 
calc’d for C14H14N2O2Cl [M+H]+: 277.0744, found 277.0715; SFC conditions: 3% IPA, 
















Product 6f was prepared according to the general procedure and isolated by silica gel 
flash column chromatography (5–10% EtOAc/hexanes) to give a colorless oil (51 mg, 
90% yield): 96% ee; [α]D25 –40.6 (c 3.4, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.91 – 
6.78 (m, 3H), 6.20 (ddd, J = 16.9, 10.3, 8.5 Hz, 1H), 5.99 (s, 2H), 5.51 – 5.37 (m, 2H), 
5.03 (d, J = 1.4 Hz, 2H), 3.86 (d, J = 8.5 Hz, 1H), 3.47 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δ 148.2, 148.1, 131.5, 127.9, 123.5, 122.5, 112.7, 109.7, 108.7, 101.5, 96.6, 70.0, 
58.1, 57.5; IR (Neat Film, NaCl) 3081, 2972, 2902, 2352, 1505, 1488, 1446, 1368, 1251, 
1238, 1164, 1108, 1039, 967, 934, 864, 817, 800, 763 cm-1; HRMS (ESI+) m/z calc’d for 
C15H15N2O4 [M+H]+: 287.1032, found 287.1039; HPLC conditions: 1% IPA, 1.0 












Product 6g was prepared according to the general procedure and isolated by silica gel 
flash column chromatography (20% EtOAc/hexanes) to give a colorless oil (54 mg, 81% 
yield): 98% ee; [α]D25 –28.2 (c 3.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.63 (s, 2H), 
6.23 (ddd, J = 16.8, 10.3, 8.5 Hz, 1H), 5.55 – 5.35 (m, 2H), 5.11 – 4.94 (m, 2H), 3.87 (m, 
7H), 3.85 (s, 3H), 3.46 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 153.4, 138.5, 131.3, 
129.7, 122.6, 112.8, 112.7, 106.6, 96.5, 69.9, 61.0, 58.5, 57.5, 56.3; IR (Neat Film, NaCl) 
2941, 2840, 244, 1591, 1509, 1463, 1418, 1333, 1245, 1163, 1127, 1034, 1007, 950, 925, 
840, 771, 719 cm-1; HRMS (ESI+) m/z calc’d for C17H21N2O5 [M+H]+: 333.1450, found 
333.1450; HPLC conditions: 7% IPA, 1.0 mL/min, Chiralpak AD column, λ = 210 nm, tR 








(R)-2-(Methoxymethoxy)-2-(1-(naphthalen-1-yl)allyl)malononitrile (6h). Product 6h 
was prepared according to the general procedure and isolated by preparatory TLC (9% 
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Et2O/hexanes, plate eluted two times) to give a colorless oil (24 mg, 41% yield): 92% ee; 
[α]D25 –30.9 (c 1.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.11 (dt, J = 8.5, 1.0 Hz, 1H), 
7.95 – 7.86 (m, 2H), 7.81 (dd, J = 7.4, 1.2 Hz, 1H), 7.60 (ddd, J = 8.6, 6.8, 1.5 Hz, 1H), 
7.57 – 7.49 (m, 2H), 6.38 (ddd, J = 16.7, 10.3, 8.2 Hz, 1H), 5.57 – 5.43 (m, 2H), 5.05 – 
4.92 (m, 3H), 3.40 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 134.1, 132.2, 132.1, 130.8, 
129.6, 129.3, 126.9, 126.6, 126.1, 125.3, 122.8, 122.7, 113.10, 112.72, 96.5, 70.1, 57.5, 
51.6; IR (Neat Film, NaCl) 3051, 2960, 2926, 2851, 2244, 1708, 1398, 1215, 1162, 1106, 
1030, 960, 925, 783 cm-1; HRMS (ESI+) m/z calc’d for C18H17N2O2 [M+H]+: 293.1290, 
found 293.1263; HPLC conditions: 1% IPA, 1.0 mL/min, Chiralpak IC column, λ = 210 








(R)-2-(Methoxymethoxy)-2-(1-(o-tolyl)allyl)malononitrile (6i). Product 6i was 
prepared according to the general procedure and isolated by silica gel flash column 
chromatography (5% EtOAc/hexanes) to give a colorless oil (33 mg, 65% yield): 89% ee; 
[α]D25 –68.7 (c 1.4, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.58 – 7.48 (m, 1H), 7.28 – 
7.19 (m, 3H), 6.22 (ddd, J = 16.9, 10.2, 8.2 Hz, 1H), 5.50 – 5.35 (m, 2H), 5.06 – 4.98 (m, 
2H), 4.34 (dd, J = 8.2, 1.0 Hz, 1H), 3.45 (s, 3H), 2.43 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δ 137.4, 133.1, 132.0, 131.2, 128.6, 128.1, 126.6, 122.5, 113.0, 112.8, 96.5, 69.8, 
57.5, 53.0, 20.3; IR (Neat Film, NaCl) 3023, 2958, 2360, 2243, 1748, 1640, 1603, 1489, 
1445, 1382, 1264, 1164, 1109, 1034, 943, 846, 792, 748, 654 cm-1; HRMS (FAB+) m/z 
calc’d for C15H17N2O2 [M+H]+: 257.1290, found 257.1280; HPLC conditions: 1% IPA, 








(R)-2-(Methoxymethoxy)-2-(1-(pyridin-3-yl)allyl)malononitrile (6j). Product 6j was 
prepared according to the general procedure and isolated by silica gel flash column 
chromatography (25% acetone/hexanes) to give a pale yellow oil (36 mg, 74% yield): 
90% ee; [α]D25 –30.8 (c 2.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.63 (dd, J = 4.7, 1.7 
Hz, 2H), 7.78 (dddd, J = 8.0, 2.3, 1.6, 0.5 Hz, 1H), 7.35 (ddd, J = 7.9, 4.8, 0.8 Hz, 1H), 
6.27 (ddd, J = 16.9, 10.3, 8.7 Hz, 1H), 5.63 – 5.39 (m, 2H), 5.06 – 4.97 (m, 2H), 4.00 (d, 
J = 8.7 Hz, 1H), 3.42 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 151.1, 150.4, 136.7, 130.4, 
130.3, 123.8, 123.7, 112.5, 112.3, 96.7, 69.4, 57.5, 56.0; IR (Neat Film, NaCl) 2963, 
2943, 2905, 2833, 2244, 1751, 1718, 1590, 1577, 1480, 1419, 1430, 1271, 1217, 1164, 
1109, 2055, 1028, 970, 941, 848, 817, 756, 714 cm-1; HRMS (FAB+) m/z calc’d for 
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C13H14N3O2 [M+H]+: 244.1086, found 244.1083; HPLC conditions: 20% IPA, 1.0 









(R)-2-(1-(Furan-2-yl)allyl)-2-(methoxymethoxy)malononitrile (6k). Product 6k was 
prepared according to the general procedure and isolated by silica gel flash column 
chromatography (10% EtOAc/hexanes) to give a colorless oil (34 mg, 73% yield): 96% 
ee; [α]D25 –44.9 (c 1.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.47 (s, 1H), 6.53 – 6.34 
(m, 2H), 6.14 (dddd, J = 16.9, 10.2, 8.5, 0.8 Hz, 1H), 5.58 – 5.43 (m, 2H), 5.10 – 4.94 
(m, 2H), 4.16 (d, J = 8.5 Hz, 1H), 3.48 (d, J = 0.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) 
δ 147.4, 143.5, 129.1, 123.5, 112.4, 112.3, 111.0, 110.4, 96.6, 68.9, 57.5, 52.4; IR (Neat 
Film, NaCl) 3125, 2091, 2964, 2942, 2905, 2833, 2245, 1499, 1444, 14222, 1270, 1217, 
1164, 1109, 1030, 922, 797, 743 cm-1; HRMS (ESI+) m/z calc’d for C12H13N2O3 [M+H]+: 
233.0926, found 233.0948; HPLC conditions: 1% IPA, 1.0 mL/min, Chiralpak IC 









(S)-2-(Methoxymethoxy)-2-(1-(thiophen-2-yl)allyl)malononitrile (6l). Product 6l was 
prepared according to the general procedure and isolated by silica gel flash column 
chromatography (10% EtOAc/hexanes) to give a colorless oil (49 mg, 98% yield): 93% 
ee; [α]D25 –40.3 (c 2.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.38 (dd, J = 5.1, 1.2 Hz, 
1H), 7.20 (ddd, J = 3.6, 1.2, 0.7 Hz, 1H), 7.08 (dd, J = 5.2, 3.6 Hz, 1H), 6.21 (ddd, J = 
16.8, 10.2, 8.6 Hz, 1H), 5.59 – 5.48 (m, 2H), 5.09 (d, J = 1.7 Hz, 2H), 4.31 (dd, J = 8.6, 
0.8 Hz, 1H), 3.52 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 135.7, 131.3, 128.3, 127.1, 
126.9, 123.0, 112.5, 112.4, 96.7, 69.8, 57.6, 54.0; IR (Neat Film, NaCl) 3090, 2963, 
2904, 2833, 2245, 2079, 1639, 1433k 1365, 1270, 1238, 1216, 1162, 1108, 1029, 922, 
856, 839, 704 cm-1; HRMS (ESI+) m/z calc’d for C12H13N2O2S [M+H]+: 249.0698, found 
249.0703; SFC conditions: 3% IPA, 3.5 mL/min, Chiralpak IC-3 column, λ = 210 nm, tR 
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Determination of Enantiomeric Excess 
 
Please note racemic products were synthesized using racemic 3. 
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 13C NMR (101 MHz, CDCl3) of compound 4c. 
 





























































































































































 13C NMR (101 MHz, CDCl3) of compound 5e. 
 




































































































































































 13C NMR (101 MHz, CDCl3) of compound 5f. 
 




















































































































































 13C NMR (101 MHz, CDCl3) of compound 5g. 
 











































































































































































 13C NMR (101 MHz, CDCl3) of compound 6a. 
 






















































































































































































 13C NMR (101 MHz, CDCl3) of compound 6b. 
 

























































































































































































 13C NMR (101 MHz, CDCl3) of compound 6c. 
 











































































































































































 13C NMR (101 MHz, CDCl3) of compound 6d. 
 












































































































































































 13C NMR (101 MHz, CDCl3) of compound 6e. 
 





































































































































































 13C NMR (101 MHz, CDCl3) of compound 6f. 
 












































































































































































 13C NMR (101 MHz, CDCl3) of compound 6g. 
 



























































































































































































 13C NMR (101 MHz, CDCl3) of compound 6h. 
 
















































































































































































 13C NMR (101 MHz, CDCl3) of compound 6i. 
 








































































































































































 13C NMR (101 MHz, CDCl3) of compound 6j. 
 



























































































































































 13C NMR (101 MHz, CDCl3) of compound 6k. 
 





































































































































































 13C NMR (101 MHz, CDCl3) of compound 6l. 
 
Infrared spectrum (Thin Film, NaCl) of compound 6l. 
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